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Abstract
In	humans,	sex	differences	in	mood	disorders	emerge	during	adolescence,	with	preva-
lence rates being consistently higher in females than males. It has been hypothesised 
that	exposure	 to	endogenous	ovarian	hormones	during	adolescence	enhances	 the	
susceptibility	of	females	to	mood	disorders	from	this	stage	of	life	onwards.	However,	
experimental	evidence	in	favour	of	this	hypothesis	 is	 lacking.	 In	the	present	study,	
we	examined	the	long-term	effects	of	suppressing	adolescent	gonadal	hormone	lev-
els	 in	a	group	of	 female	Lister-hooded	rats	via	administration	of	a	gonadotrophin-
releasing	hormone	antagonist	(Antide;	administered	on	postnatal	day	[PND]	28	and	
42) compared to control females and males (n =	14	per	group).	We	predicted	that,	in	
adulthood,	Antide-treated	female	rats	would	exhibit	more	male-like	behaviour	than	
control	females	in	novel	environments	(elevated-plus	maze,	open	field	and	light-dark	
box),	in	response	to	novel	objects	and	novel	social	partners,	and	in	an	acoustic	startle	
task.	Progesterone	and	luteinising	hormone	assays	(which	were	conducted	on	blood	
samples	 collected	on	PND	55/56	and	69/70)	 confirmed	 that	 the	hypothalamic-pi-
tuitary-gonadal	 axis	was	 temporarily	 suppressed	by	Antide	 treatment.	 In	addition,	
Antide-treated	females	were	found	to	exhibit	a	modest	pubertal	delay,	as	measured	
by	vaginal	opening,	which	was	comparable	in	length	to	the	pubertal	delay	that	has	
been	induced	by	adolescent	exposure	to	alcohol	or	stress	in	previous	studies	of	fe-
male	rats.	However,	Antide-treated	females	did	not	substantially	differ	from	control	
females	on	any	of	the	behavioural	tests,	despite	the	evidence	for	predicted	sex	dif-
ferences	in	some	measures.	Following	the	acoustic	startle	response	task,	all	subjects	
were	culled	and	perfused,	and	c-Fos	staining	was	conducted	in	the	medial	and	baso-
lateral	amygdala,	with	 the	 results	showing	no	significant	differences	 in	cell	counts	
between	the	groups.	These	findings	suggest	that	ovarian	hormone	exposure	during	
adolescence	does	not	have	long-term	effects	on	anxiety-related	responses	in	female	
rats.
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1  | INTRODUC TION
In	humans,	the	prevalence	of	mood	disorders	is	consistently	reported	
to	be	higher	in	women	than	in	men,1-3	and	this	sex	difference	in	prev-
alence emerges during adolescence.4-6 These observations have led 
to hypothesis that the fluctuations in ovarian hormone levels that 
accompany puberty increase the susceptibility to mood disorders 
amongst adolescent girls.7 This hypothesis is supported by evidence 
that	pubertal	status,	rather	than	age,	predicts	the	incidence	of	mood	
disorders8,9 and evidence that supplementation with synthetic ovar-
ian hormones during adolescence (via hormonal contraceptive use) is 
associated with a raised incidence of depression and altered physio-
logical stress responses.10-12	However,	because	these	human	studies	
are	correlational,	caution	is	required	when	inferring	a	direct	link	be-
tween	endogenous	ovarian	hormone	exposure	during	adolescence	
and long-term mental health and stress reactivity.13
Studies	 on	 laboratory	 rodents	 provide	 the	 opportunity	 to	 ex-
perimentally investigate the immediate and long-term effects of 
adolescent gonadal hormone alterations on behavioural and brain 
development.	 In	 rodents,	 adolescence	 is	 generally	 defined	 as	 the	
period	that	encompasses	pubertal	sexual	maturation14 and is char-
acterised in female rodents by vaginal opening and onset of ovarian 
cycling and in male rodents by rising testicular hormone levels and 
sperm production.15,16	Sex	differences	in	behaviour	emerge	during	
adolescence	 in	 rodents;	 for	 example,	 adolescent	male	 rats	 (Rattus 
norvegicus)	exhibit	a	higher	preference	for	novel	objects	compared	
to adolescent females17 and locomote less than aged-matched fe-
males in novel environments.18,19 The hypothalamic-pituitary-adre-
nal	(HPA)	axis	also	undergoes	significant	changes	during	adolescence	
in	rodents	and	humans,20 which means that any factors affecting the 
developing	HPA	axis	 could	have	 long-term	effects	on	 response	 to	
stressors.21
Previous	research	on	adolescent	rodents	has	shown	that	remov-
ing	gonadal	hormones	during	this	stage	of	life	has	significant,	long-
term effects on behavioural development.22,23 The majority of these 
studies have been conducted on male rodents and have compared 
the behaviour of males that were castrated before pubertal onset 
with	males	that	were	castrated	at	the	end	of	adolescence	(ie,	only	
the	 post-pubertally	 castrated	 males	 experienced	 normal	 gonadal	
hormone	 exposure	 during	 adolescence).	 Post-pubertally	 castrated	
male	rodents	are	reported	to	exhibit	higher	levels	of	aggression	and	
sexual	proficiency,	as	well	as	spend	 less	time	 in	the	aversive	areas	
of	novel	environments,	 in	adulthood	than	pre-pubertally	castrated	
male	 rats,24	 Syrian	 hamsters	 (Mesocricetus auratus)25-27 and mice 
(Mus musculus).28	These	findings	 indicate	that	exposure	to	gonadal	
hormones during adolescence influences behavioural development 
in	male	rodents,	consistent	with	the	hypothesis	that	adolescence	is	a	
‘sensitive period’ of development.29
Fewer studies have investigated the immediate and long-term 
behavioural effects of manipulating adolescent gonadal hormone 
levels	in	female	rodents;	these	studies	have	reported	that	exposure	
to gonadal hormones during adolescence increases maternal be-
haviour in adulthood (in mice30) and has organisational effects on 
subtle	aspects	of	movement	during	social	and	sexual	interactions	(in	
rats31-33).	However,	 little	 is	known	about	 the	effects	of	manipulat-
ing	adolescent	gonadal	hormones	on	anxiety-like	behaviour	or	fear	
responses.	A	 recent	 study	 reported	 that	pre-pubertally	ovariecto-
mised	Siberian	hamsters	(Phodopus sungorus) spend more time than 
controls	in	the	light	area	of	a	light-dark	box,34 whereas another study 
reported that pre-pubertally ovariectomised female rats spend less 
time in the centre of a novel open field in adulthood than sham-op-
erated	females,35 which is consistent with data from adult rodents 
showing that low oestradiol levels are associated with enhanced 
anxiety-like	behaviour	(eg,	in	rats36).	However,	the	later	study35 did 
not include a separate control group of females ovariectomised after 
puberty,	 and	 so	 any	 apparent	 long-term	 behavioural	 differences	
could reflect the activational effects of adult hormones; such effects 
are not necessarily consistent with the organisational effects of the 
same hormone at earlier life stages.24
Gonadal	 hormone	 exposure	 during	 adolescence	 could	 impact	
upon the development of brain regions that are involved in emo-
tional	processing,	 such	as	 the	 amygdala,	 ventral	 striatum	and	pre-
frontal	cortex,	which	undergo	reorganisation	in	adolescent	rodents	
and humans.37-41 Gonadal hormone receptors are located within 
these	brain	regions,41,42	and	these	regions	exhibit	sex	differences	in	
structure and function.43,44	For	example,	the	basolateral	amygdala,	
which	 is	 highly	 sensitive	 to	 stress,45	 shows	 substantial	 sex	 differ-
ences associated with emotion-related behaviours corresponding to 
greater	excitatory	synaptic	input	in	female	rats.46,47	In	addition,	the	
posterior	medial	 amygdala	 is	 sensitive	 to	 ovarian	 sex	 hormones,48 
showing robust post-pubertal differences in soma morphology and 
size.49,50	In	humans,	the	developmental	trajectories	of	the	amygdala	
and	prefrontal	cortex	have	been	reported	to	correlate	with	pubertal	
status.51-54 Given that gonadal hormones are known to influence a 
range	of	neurodevelopmental	processes,55	adolescent	hormone	ex-
posure	could	thus	potentially	have	long-term,	‘organisational’	effects	
on later affective behaviour by influencing the development of these 
brain area.
The	 present	 study	 aimed	 to	 examine	 the	 effects	 of	 suppress-
ing	ovarian	hormones	during	adolescence	on	 later	anxiety-like	be-
haviour,	 including	 responses	 to	 novelty,	 and	 amygdala	 function	 in	
female	 rats.	 Previous	 rodent	 studies	 have	 used	 ovariectomies,	 an	
approach that involves invasive surgery and results in the perma-
nent	loss	of	gonadal	function,	alongside	significant	elevation	in	cir-
culating gonadotrophin levels as a result of the permanent disruption 
of	negative-feedback	loops.	An	alternative	method	for	temporarily	
reducing gonadal hormone levels involves treatment with gonado-
tropin-releasing	 hormone	 (GnRH)	 peptide	 antagonists,	 which	 can	
be	delivered	via	subcutaneous	injection.	GnRH	peptide	antagonists	
competitively	bind	to	GnRH	receptors	in	the	pituitary,	without	acti-
vating	these	receptors	(in	contrast	to	GnRH	agonists,	which	produce	
an	 initial	 phase	 of	 hyperstimulation),	 and	 reversibly	 suppress	 go-
nadotrophin and gonadal hormone production.56 These antagonists 
have	a	long	half-life	and,	once	metabolised,	the	hypothalamic-pitu-
itary-gonadal	(HPG)	axis	is	reactivated.	Therefore,	using	a	GnRH	an-
tagonist to suppress gonadal hormone levels has several advantages 
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compared	 to	 ovariectomy,	 including	 that	 negative-feedback	 is	
maintained	 in	the	HPG	axis	and	that	 the	treatment	avoids	the	use	
of	stressful	surgical	procedures	and	is	reversible.	This	experimental	
design,	involving	juvenile	treatment	with	a	GnRH	antagonist,	delays	
the	hormonal	 changes	 that	normally	 accompany	puberty,	 allowing	
for hormone-independent developmental changes to be dissociated 
from hormone-dependent processes.
We	 examined	 the	 effects	 of	 suppressing	 ovarian	 hormones	
during	adolescence	using	a	GnRH	peptide	antagonist	 (Antide),	and	
the	goal	was	to	delay	pubertal	gonadal	hormone	exposure	to	a	sim-
ilar	 extent	 as	 seen	with	 adolescent	 exposure	 to	 alcohol	 or	 stress,	
both	of	which	can	interfere	with	HPG	functioning	during	this	period	
of life.20,57	We	predicted	that,	 in	adulthood,	Antide-treated	female	
rats	would	exhibit	more	male-like	behaviour	than	control	females	in	
novel	 environments	 (elevated-plus	maze,	 open	 field	 and	 light-dark	
box),	in	response	to	novel	objects	and	novel	social	partners,	and	in	
an	acoustic	startle	task.	Previous	studies	have	reported	behavioural	
sex	 differences	 in	 these	 tasks58;	 for	 example,	 on	 average,	 female	
rats	usually	spend	more	time	than	males	in	the	exposed	sections	of	
the	elevated-plus	maze	and	light-dark	box,18-20	and	male	rats	exhibit	
stronger acoustic startle responses than females.59,60	We	also	pos-
tulated that c-fos activation in the amygdala following the acoustic 
startle	task	would	be	greater	in	Antide-treated	females	than	in	con-
trol females.
2  | MATERIAL S AND METHODS
2.1 | Ethical statement
Ethical	guidelines,	as	set	out	in	the	Principles	of	Laboratory	Animal	
Care	(NIH,	Publication	No.	85-23,	revised	1985)	and	the	UK	Home	
Office	Animals	 (Scientific	 Procedures)	 Act	 1986,	were	 adhered	 to	
throughout	 the	 study	 (Home	Office	Project	 Licence	PC33CDA1C;	
Personal	Licences	IF9BFD0E9	and	I09B3A36E).
2.2 | Subjects and housing
The	 subjects	 comprised	42	Lister-hooded	 rats	 (28	 females	 and	14	
males) that were bred in-house (stock animals were obtained from 
Charles	 River,	Margate,	UK).	 The	 subjects	were	 derived	 from	 five	
litters,	and	an	additional	six	males	 from	these	 litters	were	used	as	
social	stimuli	in	one	of	the	behavioural	tests.	Breeding	females	were	
individually	 housed	 in	 plastic	 and	mesh	 cages	 (52	× 40 ×	 26	 cm,	
length × depth ×	height)	with	access	to	water	and	pellet	food	(DBM	
Food	 Hygiene	 Supplies	 Ltd,	 Scotland)	 available	 ad	 lib.	 Pups	 were	
weaned	at	postnatal	day	(PND)	23	and	housed	in	single-sex	sibling	
groups	until	PND	27,	then	re-housed	as	same-sex	pairs	(cage	dimen-
sions same as above) with access to water and food available ad lib. 
All	animals	were	housed	in	a	holding	room	under	a	12:12	hour	light/
dark photocycle (lights on 7.00 am) at 20 ±	1°C	and	55	±	5%	relative	
humidity.
2.3 | Experimental design
Three sets of subjects were produced: (i) females (n = 14) that were 
treated	on	PND	28	and	42	with	a	gonadotrophin-releasing	hormone	
(GnRH)	peptide	antagonist,	Antide	(Bachem,	Germany),	via	s.c.	injec-
tion	at	a	dose	of	6	mg	kg-1	 in	1:1	propylene	glycol:	saline	solution,	
as in our previous research61	 (injection	volumes	 [μL]	were	2× ani-
mal	weight	[g]);	(ii)	females	(n	= 14) that received vehicle (propylene 
glycol:	saline	solution)	injections	on	PND	28	and	42;	and	(iii)	males	
(n =	14)	that	received	vehicle	injections	on	PND	28	and	42	(as	a	re-
sult	of	practical	constraints,	 four	males	received	the	first	 injection	
on	PND	29	rather	than	PND	28).	Each	bolus	of	Antide	was	predicted	
to suppress circulating gonadal hormone levels for between 2 and 
3	weeks,	 as	 in	 previous	 studies,61,62 and so the regime of two in-
jections 14 days apart was designed to suppress gonadal hormone 
levels from the late juvenile phase through to the end of late ado-
lescence (age ranges based on previous studies18,63).	No	more	than	
five	animals	 from	each	 litter	were	assigned	 to	a	single	experimen-
tal	group,	and,	in	the	majority	of	cases,	no	more	than	four	females	
from	a	single	litter	were	used	as	subjects	in	the	experiment	(ie,	two	
Antide-treated	 females	and	 two	control	 females),	with	all	 subjects	
paired	with	a	littermate	in	the	same	experimental	group.
All	subjects	were	weighed	once	per	week	from	PND	28	onwards.	
Vaginal opening (VO) was assessed in female subjects daily by vi-
sual	inspection	from	PND	28,	with	VO	recoded	as	the	first	day	when	
the	vagina	was	either	partially	or	fully	opened,	and	males	received	
similar	handling	each	day.	Previous	studies	have	shown	that	vaginal	
opening	typically	occurs	around	PND	32-34	in	rats.64,65	Anogenital	
distance	 (AGD)	was	measured	 for	 all	 subjects	 on	 PND	35	 and	 49	
using	electronic	calipers,	with	care	being	taken	not	to	touch	the	gen-
ital	area	with	the	caliper	tips,	given	that	artificial	genital	contact	can	
accelerate	sexual	maturation	in	adolescent	rats.66
Behavioural	 testing	 was	 undertaken	 during	 adolescence	 (PND	
40-44)	and	adulthood	(PND	79-103).	All	subjects	underwent	all	of	
the behavioural tests in the order: (i) adolescent social behaviour 
(PND	40-44);	(ii)	response	to	novel	environments	(PND	79-85);	(iii)	
response	to	novel	objects	and	social	partners	(PND	89-92);	and	(iv)	
the	acoustic	startle	response	(ASR)	task	(PND	98-103,	followed	by	
perfusion	90	minutes	after	the	ASR	task).	The	same	order	of	testing	
was	maintained	for	all	subjects,	as	in	previous	studies	in	our	labora-
tory,18,19 because some tests had to be conducted at specific subject 
ages	(adolescent	social	behaviour)	and	the	ASR	test	had	to	precede	
perfusion	for	all	 subjects.	Although	this	design	does	not	allow	the	
estimation of any carry-over effects that might result from the order 
of	behavioural	testing,	between-group	comparisons	remain	valid.	All	
behaviour tests took place in a single testing room with the relevant 
piece of apparatus set-up directly below the ceiling-mounted cam-
era,	 and	 a	 black	 curtain	 separated	 the	 apparatus	 from	 the	 rest	 of	
the testing room. Individual subjects were transported to the testing 
4 of 14  |     HODGSON et al.
room	in	a	carrying	box	and	returned	to	the	home-cage	immediately	
after completing the test.
Information on ovarian cyclicity was not collected for the female 
subjects	 in	 this	 experiment	 for	 three	 reasons.	 First,	 our	 research	
question	did	not	involve	investigating	cycle-dependent	effects,	and	
it	has	been	suggested	previously	that	experimental	designs	do	not	
need to take ovarian stage into account unless the study is specifi-
cally	investigating	cycle-dependent	effects,67,68 particularly because 
the behaviour of unstaged females is not more variable than that of 
males.69	 Second,	we	did	not	 require	 cyclicity	 data	 to	 confirm	 that	
Antide	treatment	had	been	successful	because	hormonal	and	vag-
inal	opening	data	were	considered	to	be	sufficient.	Third,	cyclicity	
monitoring	would	 have	 required	 swab	 sampling	 to	 be	 undertaken	
alongside	the	behavioural	testing,	which	could	have	induced	stress	
in both of the female groups (but not in the control male group) and 
thereby impacted upon the behaviour of subjects and influenced be-
tween-group comparisons.
Blood	 samples	were	 taken	 from	 tail	 veins	 on	 PND	 55/56	 and	
69/70,	 under	 gas	 anaesthesia	 (isofluorane),	 to	 confirm	 that	 treat-
ment	with	Antide	successfully	suppressed	the	HPG	axis,	and	serum	
was	stored	at	−70°C	prior	to	assaying	of	progesterone	and	luteinising	
hormone	(LH)	levels.	All	subjects	were	culled	via	perfusion	following	
the	final	behavioural	 test	 (ie,	90	minutes	after	 the	acoustic	startle	
response	task)	on	PND	98-103,	and	the	brain	tissue	was	sectioned,	
mounted	and	frozen	at	−20°C	prior	to	c-Fos	immunohistochemistry	
and cell counting.
2.4 | Behavioural testing
2.4.1 | Adolescent social behaviour
On	PND	40,	41,	43	and	44,	subjects	were	paired	with	a	same-aged,	
same-sex	 partner	 from	 the	 same	 experimental	 group	 (ie,	 not	 the	
cage-mate	 [insufficient	non-experimental	 animals	of	 the	 same	age	
were available to conduct the social behaviour tests with fully naïve 
animals]).	Social	 interaction	sessions	took	place	 in	a	perspex	arena	
(49 × 44 ×	47	cm,	length	× width × height). The outer walls of the 
arena	were	black,	and	light	illuminance	in	the	arena	was	maintained	
at	approximately	40	lux.	A	ceiling-mounted	camera	relayed	video	to	
a	computer,	and	the	arena	floor	was	divided	visually	into	four	equal	
quadrants.	A	black	curtain	occluded	views	of	the	testing	room	and	
the	experimenter.	Subjects	were	transported	to	the	testing	room	in	
an	enclosed	box,	and	the	arena	was	cleaned	with	disinfectant	solu-
tion	after	each	test.	On	PND	35,	37	and	39,	each	pair	of	cage-mates	
was	given	a	5-minute	habituation	session	in	the	arena,	then	returned	
to	 the	 home-cage.	 The	 social	 behaviour	 tests	 were	 subsequently	
conducted	on	4	days	(PND	40,	41,	43	and	44)	to	provide	sufficient	
behavioural data. The two subjects were placed into the arena for 
a	10-minute	test,	then	returned	to	the	respective	home-cages.	The	
apparatus	was	 cleaned	with	 liquid	 disinfectant	 after	 each	 test.	As	
a	result	of	limited	numbers	of	potential	partners,	each	subject	was	
paired	with	two	different	animals	across	the	four	sessions	 (ie,	one	
partner	 on	 PND	40	 and	 43,	 and	 another	 partner	 on	 PND	41	 and	
44),	rather	than	four	different	animals.	For	each	test,	the	(i)	total fre-
quency of social investigations	(ie,	sniffing	the	partners	face,	body	or	
anogenital region) and (ii) social play	(ie,	nape-attack,	pinning,	boxing,	
chasing and evasion) was calculated (definitions in accordance with 
previous research70,71).
2.4.2 | Response to novel environments 
in adulthood
Elevated-plus maze (EPM)
All	subjects	were	tested	once	on	the	EPM	on	either	PND	79,	80	or	
81.	 The	 EPM	was	 a	wooden,	 grey-painted	maze	 that	 consisted	 of	
four	arms	(51	cm	×	11	cm,	length	×	width)	extending	from	a	central	
area (11 cm × 11 cm). Two of the opposing arms were enclosed by 
walls (40 cm height; ‘closed’ arms) and the other two opposing arms 
lacked	walls	(‘open’	arms).	The	maze	was	raised	56	cm	off	the	floor	
on	a	metal	frame,	and	the	light	illuminance	was	~30	lux	on	the	closed	
arms and ~65	lux	on	the	open	arms.	At	the	start	of	a	test,	the	subject	
was	placed	into	the	central	area,	facing	an	open	arm.	Each	test	lasted	
5	minutes,	 and	 the	apparatus	was	cleaned	with	 liquid	disinfectant	
after each test. The following behavioural measures were calculated: 
(i) total number of entries into the open arms,	(ii)	total number of entries 
into the closed arms,	(iii)	percentage of time spent on the open arms,	and	
(iv) percentage of time spent on the closed arms.
Open field (OF)
All	 subjects	were	 tested	once	 in	 the	OF	on	PND	82.	The	OF	con-
sisted of an area of vinyl floor (120 cm ×	120	cm,	 length	× width) 
enclosed	 on	 all	 four	 sides	 by	 a	wooden,	 grey-painted	wall	 (50	 cm	
height). The floor of the arena was marked into nine areas (8 outer 
and	1	central	area)	by	lines	that	were	located	20	cm	in	from	the	walls,	
and	the	light	illuminance	at	floor	level	was	approximately	50	lux.	At	
the	start	of	the	test,	a	subject	was	placed	into	the	outer	areas	and	
left	 in	the	area	for	5	minutes.	The	apparatus	was	cleaned	with	liq-
uid disinfectant after each test. The following behavioural measures 
were calculated: (i) total number of transitions between areas (both 
outer areas and centre) and (ii) total percentage of time spent in the 
centre vs the outer areas.
Light-dark box (LDB)
All	 subjects	 were	 tested	 once	 in	 the	 LDB	 on	 either	 PND	 83,	 84	
or	 85.	 The	 LDB	 apparatus	 consisted	 of	 a	 Perspex	 arena	 that	was	
separated	 into	 two	 sections	 using	 an	 opaque	 plastic	 divider	 with	
an opening at floor level (11-cm diameter archway). The ‘light’ sec-
tion (70 × 44 ×	47	cm,	length	× width × height) had white walls and 
was	illuminated	to	approximately	90	lux,	and	a	smaller	‘dark’	section	
(49 × 44 ×	47	cm,	length	× width × height) had black walls and an 
opaque	 lid.	At	 the	start,	 the	subject	was	placed	 into	 the	dark	sec-
tion,	and	the	test	lasted	for	5	minutes.	The	apparatus	was	cleaned	
with	 liquid	 disinfectant	 after	 each	 test.	 The	 following	 behavioural	
measures were calculated: (i) latency to enter the light section; (ii) total 
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number of transitions between the dark and the light sections; and (iii) 
percentage of time spent in the light section.
2.4.3 | Response to novel objects and social 
partners in adulthood
Novel object (NO) test
All	 subjects	underwent	 the	NO	test	on	PND	89.	The	test	was	con-
ducted	 in	 a	 painted,	 wooden	 arena	 measuring	 67	 ×	 67	 ×	 45	 cm	
(length × width × height). The arena floor was divided visually into 
four	equal	quadrants,	and	the	light	illuminance	was	approximately	20	
lux	at	floor	level.	Three	novel	objects	were	used	that	were	similar	in	
size	but	differed	in	texture	(glass	or	plastic)	and	colour	(blue,	pink	or	
clear).	During	the	first	stage	of	the	test,	two	objects	were	placed	into	
the	arena,	 and	one	 in	each	of	 two	adjacent	quadrants.	The	 subject	
was	then	placed	in	the	empty	half	of	the	arena,	facing	away	from	the	
novel	objects,	and	allowed	to	explore	for	3	minutes.	The	subject	was	
then	 removed	and	placed	 into	a	carrying	box	 for	2	minutes,	during	
which time the objects were removed and both the arena and the ob-
jects	were	cleaned	with	liquid	disinfectant.	One	of	the	original	objects	
was	then	placed	back	into	the	arena	in	 its	original	position,	and	the	
third object was placed into the position previously occupied by the 
removed object. The subject was returned to the arena for a 3-min-
ute	period,	 then	returned	to	 the	home-cage	and	the	apparatus	and	
objects cleaned. The objects were counterbalanced across subjects. 
In	the	NO	test,	time	spent	exploring	the	novel	objects	can	be	used	as	
a	measure	of	anxiety-like	behaviour,	whereas	the	relative	time	spent	
exploring	the	novel	and	familiar	object	can	either	reflect	novelty	pref-
erence or short-term memory.72 The following specific behavioural 
measures were calculated: (i) total amount of time in each quadrant 
containing an object and (ii) a novel object preference score (defined as 
[(time	with	novel	object	–	time	with	familiar	object)/(time	with	novel	
object +	time	with	familiar	object)]	×	100,	as	in	previous	research17,61).
Social novelty (SN) test
All	subjects	were	tested	once	in	the	SN	on	either	PND	90,	91	or	92.	
The	SN	apparatus	consisted	of	a	perspex	arena	(119	× 44 ×	47	cm,	
length × width ×	height;	approximately	15	lux)	that	contained	two	
clear	perspex	boxes	(24	× 21 ×	46	cm,	 length	× width × height) in 
opposite	corners	of	the	arena.	One	of	the	boxes	contained	a	male	
stimulus	animal	and	the	other	contained	a	novel	object	(a	blue,	yel-
low	or	blue-and-yellow	plastic	object,	with	objects	counterbalanced	
across	subjects).	Stimulus	animals	received	two	habituation	sessions	
in the apparatus and were used for no more than two consecutive 
tests.	 In	 one-half	 of	 the	 sessions,	 the	 animal	was	 in	 the	 box	 clos-
est	to	the	testing	room	door	and,	in	the	remaining	sessions,	the	ani-
mal	was	in	the	other	box.	The	arena	was	divided	visually	into	three	
areas,	 two	of	which	 included	one	of	 the	boxes	 (49	× 44 ×	47	cm,	
length × width × height) plus a smaller central area (21 × 44 ×	47	cm,	
length × width × height). The subject was placed into the central area 
and	allowed	 to	explore	 for	5	minutes.	The	apparatus	was	 cleaned	
with	 liquid	 disinfectant	 after	 each	 test.	 The	 following	 behavioural	
measures were calculated: (i) total amount of time spent in the area 
containing the social partner or the novel object and (ii) total number of 
entries into each area.
2.4.4 | Acoustic startle response (ASR) task
All	subjects	were	tested	once	in	the	ASR	task	between	PND	98	and	
103.	The	 task	was	conducted	 in	a	perspex	box	 (49	× 44 ×	47	cm,	
length × width ×	height)	that	was	illuminated	at	approximately	90	lux	
at floor level and had an electronic speaker attached to the top of 
one of the walls. The speaker was connected to a laptop computer 
and audacity (https://www.audac ityte am.org) was used to play a se-
ries	of	1-second	bursts	of	white	noise	at	a	volume	of	approximately	
90	decibels.	The	subject	was	placed	into	the	arena	and,	after	45	sec-
onds,	 the	 first	 startle	noise	was	played	via	 the	speaker.	The	noise	
was	then	repeated	every	subsequent	30	seconds,	resulting	in	a	total	
of	nine	acoustic	startle	stimuli	across	a	5-minute	test.	The	apparatus	
was	cleaned	with	liquid	disinfectant	after	each	test.	As	in	previous	
studies,73	 immobility,	 or	 ‘freezing’	 behaviour,	was	 coded	 from	 the	
videos,	and	the	following	behavioural	measures	were	calculated:	(i)	
total number of times that the startle noise resulted in the animal becom-
ing immediately immobile	 (ie,	number	of	 ‘freezes’,	range	0-9)	and	(ii)	
summed duration of time (seconds) spent immobile following the startle 
noises	(ie,	duration	of	‘freezing’).	Because	we	did	not	have	access	to	
an	electronic	startle	monitor,	we	were	unable	to	evaluate	additional	
measures,	such	as	startle	amplitude;	however,	 ‘freezing’	behaviour	
has previously been shown to correlate with startle amplitude in fe-
male rats.74	At	the	end	of	the	ASR	task,	the	subject	was	returned	to	
the home-cage for 90 minutes before being culled for brain tissue 
collection.
2.5 | Hormone assays
2.5.1 | Progesterone assay
Serum	 progesterone	 levels	 were	 measured	 using	 a	 commercially	
available progesterone enzyme-linked immunosorbent assay kit 
(ADI-900-011;	 Assay	 Designs,	 Enzo	 Life	 Sciences,	 Exeter,	 UK).	
Serum	 samples	were	diluted	with	 assay	buffer	 (sera	 from	 females	
were	diluted	1:100,	sera	from	males	were	diluted	1:25)	and	100	µL	
of each diluted sample was assayed in duplicate. The assay has a de-
tection	limit	of	8.57	pg	mL-1,	an	intra-assay	coefficient	of	variation	of	
5.4%	and	an	inter-assay	coefficient	of	variation	of	8.3%.
2.5.2 | LH assay
Serum	 LH	 levels	were	measured	 using	 established	 in-house	 enzyme-
linked immunosorbent assays as described previously.75	Serum	samples	
were assayed neat or diluted (1:10) when necessary and 20 µL	of	each	
sample	 was	 assayed	 in	 duplicate.	 The	 3,3',5,5'-tetramethylbenzidine	
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substrate	 (34021;	 Thermo	 Scientific,	Waltham,	MA,	USA)	was	 devel-
oped for 30 minutes at room temperature and stopped by the addition of 
2	mol	L-1	H2SO4.	The	absorbance	in	each	well	was	then	read	at	450	nm.	
The	assay	had	a	detection	limit	of	0.05	ng	mL-1,	an	intra-assay	coefficient	
of	variation	of	2.2%	and	an	inter-assay	coefficient	of	variation	of	<	10%.
2.6 | Immunohistochemistry and cell counting
At	 the	end	of	 the	behavioural	 testing	 (ie,	 90	minutes	 after	 the	ASR	
task),	 rats	 were	 transcardially	 perfused	 with	 4%	 paraformaldehyde	
in	 0.1	 mol	 L-1 phosphate buffer after anaesthesia with Euthatal® 
(Dopharma	 Research	 B.V.,	 Raamsdonksveer,	 The	 Netherlands)	
(1.0	mL	kg-1,	pentobarbital	sodium	administered	i.p.	200	mg	mL-1). The 
brain	tissue	was	removed,	post-fixed	and	stored	overnight	in	20%	su-
crose	solution	at	4°C.	The	tissue	was	then	set	 in	egg	yolk	and	fixed	
via	exposure	to	40%	formaldehyde	for	72	hours.	Prior	to	sectioning,	
the left-hand side of the egg yolk was marked using a needle punc-
ture to allow the hemispheres to be identified. The tissue was cut into 
40 μm	coronal	sections	using	a	freezing	microtome	(SM	2010R;	Leica	
Microsystems,	Wetzlar,	 Germany),	 then	 stored	 in	 ethylene	 glycol	 in	
sucrose	solution	at	−20°C.	After	being	removed	from	the	freezer,	the	
sections	 were	 rinsed	 in	 phosphate-buffered	 saline	 (PBS)	 and	 every	
fourth	 section	 (between	1.30	mm	to	4.52	mm	posterior	 to	Bregma)	
was	mounted	onto	SuperFrost	Plus	 slides	 (Thermo	Scientific).	Slides	
were	 then	 dried	 at	 37°C	 for	 30	minutes	 and	 stored	 at	 −20°C.	One	
set of sections for each subject then underwent c-Fos immunohisto-
chemistry	labelling	using	the	Vectastain	ABC	kit	with	Rabbit	IgG	(PK-
6101)	in	combination	with	the	DAB	peroxidase	substrate	kit	(SK-4100)	
(Vector	Laboratories,	Burlingame,	CA,	USA).	Briefly,	the	sections	un-
derwent	heat-induced	epitope	retrieval	by	 immersion	in	10	mmol	L-1 
sodium	citrate	 (pH	6)	at	>	90°C	for	10	minutes.	Sections	were	then	
incubated	in	PBS	for	5	minutes	before	being	covered	with	BLOX-ALL	
reagent	(SP-6000;	Vector	Laboratories)	for	10	minutes.	Sections	were	
washed	in	PBS	for	5	minutes	before	incubation	with	blocking	serum	
for 20 minutes (100 μL	per	section).	Blocking	serum	was	then	removed	
and	 a	 rabbit	 anti-c-Fos	 antibody	 (dilution	1:1000;	 sc-52;	 Santa	Cruz	
Biotechnology,	Santa	Cruz,	CA,	USA)	was	applied	(100	μL	per	section),	
and sections were incubated overnight at 4°C in a humidified slide tray. 
The	next	day,	sections	were	washed	three	times	in	PBS	and	incubated	
with	 biotinylated	 secondary	 antibody	 (anti-rb	 IgG)	 for	 45	 minutes	
(100 μL	per	section),	then	immersed	in	ABC	reagent	for	45	minutes	and	
then	washed	again	times.	The	sections	were	then	incubated	in	peroxi-
dase	substrate	solution	for	9	minutes,	rinsed	in	tap	water	and	mounted	
using	Fluoromount-G	(00-4958-02;	Invitrogen,	Carlsbad,	CA,	USA).
Slides	 were	 imaged	 using	 a	 Axio	 Scan	 Z1	 scanner	 (Carl	 Zeiss,	
Oberkochen,	Germany)	and	quantification	of	c-Fos	labelling	was	un-
dertaken in four nuclei of the medial amygdala and three nuclei of the 
basolateral amygdala (right hemisphere only; n =	9	per	group).	At	the	
anterior	level	of	the	medial	amygdala,	this	included	the	dorsal	(MeAD)	
and	ventral	(MeAV)	nuclei	and,	at	the	posterior	level,	this	included	the	
dorsal	 (MePD)	and	ventral	 (MePV)	nuclei.	At	 the	 level	of	 the	baso-
lateral	amygdala,	this	included	the	anterior	(BLA),	posterior	(BLP)	and	
ventral	(BLV)	nuclei.	Using	qupath,	version	0.1.2,76 regions of interest 
were	outlined	with	reference	to	the	rat	brain	atlas,77 and c-Fos posi-
tive	cells	were	quantified	using	the	‘positive	cell	detection’	function.	
The	threshold	for	cell	detection	was	set	between	0.30	and	0.52,	ad-
justed	to	account	for	differing	levels	of	background	staining.	Sections	
from	1.30	mm	to	2.80	mm	posterior	to	Bregma	were	analysed	for	the	
MeAD;	for	the	MeAV,	from	2.12	mm	to	2.30	mm	posterior	to	Bregma;	
for	 the	MePD,	 from	2.80	mm	to	3.60	mm	posterior	 to	Bregma;	 for	
the	MePV,	 from	2.56	mm	to	3.30	mm	posterior	 to	Bregma:	 for	 the	
BLA,	 from	1.60	mm	 to	3.30	mm	posterior	 to	Bregma;	 for	 the	BLP,	
from	2.30	mm	to	4.52	mm	posterior	to	Bregma;	and,	for	the	BLV,	from	
2.30	mm	to	3.60	mm	posterior	 to	Bregma.	Between	four	and	eight	
sections	were	analysed	per	animal,	and	values	were	averaged	over	the	
available	sections	for	each	region.	The	experimenter	was	blind	to	the	
animal ID and treatment groups during the cell counting.
2.7 | Statistical analysis
Analyses	were	conducted	using	spss,	version	23	(IBM	Corp.,	Armonk,	
NY,	USA)	and	r,	version	3.5.3	(R	Foundation	for	Statisitical	Computing,	
Vienna,	 Austria).	 Body	 weight	 and	 AGD	 data	 were	 analysed	 using	
repeated-measures	ANOVAs	(for	one	control	female,	AGD	data	were	
not included as a result of a missing value) and VO data were analysed 
using an independent samples t	 test.	Hormone	 data	were	 analysed	
using	non-parametric	statistics	 (Kruskal-Wallis	 test	and	Dunn's	post-
hoc	 test	with	Bonferroni	 correction)	as	a	 result	of	a	 lack	of	normal-
ity	 in	 the	data.	One	Antide-treated	female	did	not	appear	to	exhibit	
suppression	of	the	HPG	axis	(ie,	both	the	progesterone	and	LH	serum	
levels	fell	above	of	the	95%	percentile	on	PND	55/56),	which	strongly	
suggests	that	the	Antide	treatment	was	not	successful	for	this	subject,	
and	the	data	for	this	female	were	therefore	excluded	from	all	analy-
ses (whether this subject was included or not had minimal effects on 
the	alpha	values	throughout).	Adolescent	social	interaction	data	were	
analysed	using	a	 repeated-measures	ANCOVA,	with	PND	as	 the	 re-
peated measure and the identity of the play partner as a covariate. The 
EPM	 and	 SN	 data	were	 analysed	 using	 repeated-measures	 ANOVA	
with	Tukey’s	post-hoc	test	 (in	the	EPM	analyses,	one	Antide-treated	
female	was	excluded	because	the	animal	left	the	apparatus	during	the	
test) and the remaining behavioural data were analysed using one-way 
ANOVAs.	Cell	count	data	were	analysed	using	two	repeated-measures	
ANOVAs.	All	data	are	presented	as	the	mean	±	SD,	except	hormone	
data,	which	are	presented	as	medians	and	interquartile	ranges.
3  | RESULTS
3.1 | Body weight
Antide-treated	 and	 control	 females	 did	 not	 differ	 in	 body	 weight	
(F1,25 =	0.39,	P =	0.540)	(Figure	1)	and	the	interaction	between	group	
and age was also not significant (F9,225 =	1.65,	P = 0.103). The main 
effect of age was significant (F9,225 =	1843.89,	P < 0.001).
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3.2 | VO and AGD
Antide-treated	 females	 exhibited	 VO	 at	 a	 significantly	 older	
age	 (PND	 36.7	 ±	 3.04	 days)	 compared	 to	 control	 females	 (PND	
33.9 ± 1.94 days) (t26 =	 2.84,	P =	 0.009).	As	 expected,	AGD	was	
smaller	at	PND	35	than	at	PND	49	(F1,24 =	780.92,	P < 0.001); how-
ever,	AGD	did	not	differ	 significantly	between	Antide-treated	and	
control females (F1,24 =	0.16,	P =	0.679)	and	the	interaction	between	
group and age was not significant (F1,24 =	0.52,	P =	0.476;	PND	35:	
Antide-treated	= 14.8 ± 1.4 mm; control =	15.1	±	1.0	mm;	PND	49:	
Antide-treated	= 21.3 ± 1.0 mm; control = 21.4 ± 1.4 mm).
3.3 | Hormone levels
Serum	progesterone	levels	differed	significantly	between	groups	at	
PND	55/56	(P <	0.001)	(Table	1),	with	Antide-treated	females	having	
lower average progesterone levels than control females and higher 
average progesterone levels than control males (all pairwise compar-
isons,	P <	0.05).	At	PND	69/70,	serum	progesterone	levels	differed	
between groups (P < 0.001) as a result of control males having lower 
average progesterone levels than both control females (P < 0.001) 
and	Antide-treated	females	(P <	0.001),	with	no	difference	between	
the two groups of females (P = 1.000).
Serum	 LH	 levels	 differed	 between	 groups	 at	 PND	 55/56	
(P =	 0.001)	 (Table	 1)	 as	 a	 result	 of	Antide-treated	 females	 having	
lower	 average	 LH	 levels	 than	 both	 control	males	 (P = 0.001) and 
control females (P =	0.017),	whereas	control	males	had	similar	LH	
levels to control females (P =	1.000).	At	PND	69/70,	serum	LH	levels	
differed between groups (P = .0007) as a result of control males hav-
ing	higher	average	LH	levels	than	Antide-treated	females	(P =	0.015)	
and control females (P =	0.028),	with	no	difference	between	the	two	
female groups (P = 1.000).
3.4 | Adolescent social behaviour
The total number of social interactions did not differ between 
groups (F2,15 =	1.07,	P =	0.367)	and	did	not	differ	across	postnatal	
days (F3,45 =	1.92,	P =	0.140)	(Figure	2).	Although	Antide-treated	
females	exhibited	a	reduction	in	social	interactions	on	PND	43	(ie,	
1	day	after	the	second	Antide	injection),	the	interaction	between	
group and day was not significant (F6,45 =	1.36,	P =	0.262).
3.5 | Response to novel environments in adulthood
3.5.1 | EPM
The total number of entries onto open arms and closed arms of the 
EPM	(ie,	sum	of	open	and	closed	arm	entries)	differed	significantly	be-
tween groups (F2,37 =	9.67,	P <	0.001)	(Figure	3A)	as	a	result	of	control	
males	making	fewer	transitions,	on	average,	than	both	control	females	
(P =	0.003)	and	Antide-treated	females	(P = 0.001). The main effect 
of arm type was not significant (F1,37 =	1.15,	P =	0.291),	neither	was	
the interaction between group and arm type (F2,37 =	0.64,	P =	0.531).
The	percentage	of	time	spent	in	either	the	open	or	closed	arms	(ie,	
time in open arms plus time in closed arms) differed between groups 
(F2,37 =	 3.35,	P =	 0.046),	which	 can	be	 explained	by	 control	males	
spending	more	time,	on	average,	in	the	alternative,	central	area	of	the	
EPM	(31.1	±	10.0%)	than	control	females	 (23.8	±	6.4%;	P =	0.036),	
but	 not	Antide-treated	 females	 (27.4	±	 4.71%;	P =	 0.428),	with	 no	
difference between female groups (P = 0.444). The percentage of 
time spent in open arms vs closed arms did not differ (F1,37 =	3.26,	
P = 0.079) and the interaction between group and time spent in the 
open vs closed arms was also non-significant (F2,37 =	1.30,	P =	0.285).
3.5.2 | OF
The total number of transitions between sections of the OF dif-
fered between groups (F2,38 =	8.64,	P <	0.001)	(Figure	3B),	with,	
on	average,	control	males	making	fewer	transitions	than	Antide-
treated females (P = 0.002) and control females (P =	0.004),	with	
no difference between female groups (P =	0.952).	The	percentage	
of time spent in the centre of the OF did not differ between groups 
(F2,38 =	 0.94,	P = 0.398; control males = 19.0 ±	 11.2%;	Antide-
treated females = 21.7 ±	6.1%;	control	females	= 23.7 ±	8.8%).
3.5.3 | LDB
The	 total	 number	of	 transitions	 between	 sections	of	 the	 LDB	dif-
fered between groups (F2,38 =	 3.77,	 P =	 0.032)	 (Figure	 4A),	 with	
control	males,	on	average,	exhibiting	fewer	transitions	than	control	
females (P =	 0.041),	 but	 not	 Antide-treated	 females	 (P =	 0.091),	
and with no difference between female groups (P =	0.944).	Latency	
to	 enter	 the	 light	 section	 of	 the	 LDB	 differed	 between	 groups	
F I G U R E  1  Body	weight	of	Antide-treated	females	(AF,	solid	line,	
n =	13)	and	control	females	(CF,	dotted	line,	n	= 14) (mean ±	SD).	
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(F2,39 =	 3.40,	 P =	 0.044)	 (Figure	 4B)	 as	 a	 result	 of	 control	 males	
having a longer latency (14.4 ±	13.5	seconds)	than	control	females	
(5.4	 ±	 6.2	 seconds;	 P =	 0.040),	 but	 not	 Antide-treated	 females	
(8.0 ±	6.2	seconds;	P =	0.195),	with	no	difference	between	the	fe-
male groups (P =	0.750).	The	percentage	of	time	spent	 in	the	 light	
section did not differ between groups (F2,38 =	2.66,	P = 0.083; con-
trol males = 37.3 ±	8.3%;	Antide-treated	females	= 44.3 ±	7.6%;	con-
trol females = 43.0 ±	9.4%).
3.6 | Response to novel objects and social partners 
in adulthood
3.6.1 | NO test
Total amount of time spent in the same section of the arena as 
the novel object did not differ between groups (F2,38 =	 3.18,	
P =	 0.053;	 control	 males	 = 90.0 ±	 21.9	 seconds;	 Antide-treated	
females = 78.7 ±	16.5	seconds;	control	females	= 73.4 ± 14.2 sec-
onds). The novel object preference score revealed a main effect 
of group (F2,38 =	 3.50,	 P =	 0.040),	 with	 control	 males	 having	 a	
higher average preference score (23.3 ± 21.1) than control females 
(2.7 ± 22.0; P =	0.030),	but	not	Antide-treated	females	(11.9	± 18.2; 
P =	 0.333),	 with	 no	 difference	 between	 the	 two	 female	 groups	
(P =	0.486).
3.6.2 | SN test
The percentage of time spent in the same section of the arena as the 
novel	object	or	the	social	partner	(ie,	sum	of	the	percentage	of	time	
spent in these two sections) differed between groups (F2,38 =	4.04,	
P =	0.026)	as	a	result	of	control	males	spending	slightly	more	time	
in	the	third,	central	section	of	the	arena	(16.8	±	5.4%)	than	Antide-
treated females (12.4 ±	4.1%,	P =	0.026),	but	not	more	than	control	
females	(13.6	±	2.7%,	P =	0.114;	Antide-females	vs	control	females,	
P =	0.763).	Across	all	groups,	subjects	spent	more	time	in	the	sec-
tion of the arena with the social partner than with the novel ob-
ject (F1,38 =	235.18,	P <	0.001)	(Figure	5).	The	interaction	between	
group and section of the arena was non-significant (F2,38 =	 1.42,	
P =	0.254).
3.7 | ASR
The total number of immobilisation responses differed between 
groups (F2,38 =	4.34,	P =	0.020)	 (Figure	6A),	with	control	males,	
on	 average,	 exhibiting	 a	 higher	 number	 of	 immobilisations	 than	
control females (P =	 0.022),	 but	 not	 Antide-treated	 females	
(P =	 0.081),	 with	 no	 difference	 between	 the	 female	 groups	
(P =	 0.868).	 The	 time	 spent	 immobile	 following	 a	 startle	 noise	
also differed significantly between groups (F2,38 =	7.34,	P = .002) 
(Figure	6B),	with	control	males,	on	average,	spending	 longer	 im-
mobile than both control females (P =	0.004)	and	Antide-treated	
females (P =	0.009),	with	no	difference	between	the	two	female	
groups (P =	0.960).
3.8 | Cell counts
Cell	counting,	which	was	carried	out	on	the	tissue	sections	that	
were	collected	90	minutes	after	the	ASR	task,	revealed	that	the	
Control males
Antide-treated 
females
Control 
females
Progesterone	
(ng	mL-1)
PND	55/56 1.00	(0.52)*,# 5.38	(2.59)#  9.13 (4.93)
PND	69/70 0.57	(0.44)**,## 8.07 (4.79) 10.29	(12.69)
LH	(ng	mL-1) PND	55/56 0.77 (0.40)** 0.35	(0.27)#  0.77	(0.62)
PND	69/70 0.83	(0.26)*,# 0.39 (0.47) 0.47 (0.32)
*P <	0.05,	
**P <	0.001	vs	Antide-treated	females;	
#P <	0.05,	
##P <	0.001	vs	control	females,	(Kruskal–Wallis	with	Dunn's	post-hoc).	
TA B L E  1  Serum	progesterone	and	
luteinising	hormone	(LH)	levels	in	control	
males (n =	14),	Antide-treated	females	
(n = 13) and control females (n = 14) at 
postnatal	day	(PND)	55/56	and	PND	
69/70	(data	are	presented	as	medians	with	
interquartile	ranges)
F I G U R E  2   Total number of social interactions with a novel 
partner	exhibited	by	control	males	(CM,	n	=	14),	Antide-treated	
females	(AF,	n	=	13)	and	control	females	(CF,	n	= 14) during 
10-minute	tests	on	postnatal	day	(PND)	40,	41,	43	and	44	
(mean ±	SD)
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number	 of	 c-Fos	 positive	 cells	 in	 the	 medial	 amygdala	 (MeA)	
nuclei did not differ between groups (F2,17 =	 2.29,	 P = 0.132) 
(Table	2)	or	between	MeA	regions	(F3,51 =	2.50,	P =	0.070),	and	
the interaction between group and region was not significant 
(F6,51 =	1.45,	P =	0.214)	(see	Supportiing	information,	Figure	S1).	
Cell	 counts	 in	 the	basolateral	amygdala	 (BL)	nuclei	also	did	not	
differ between groups (F2,24 =	 0.51,	 P =	 0.607);	 however,	 cell	
counts	did	differ	between	BL	regions	(F2,48 =	21.35,	P < 0.001) 
as	a	result	of	higher	average	cell	counts	in	the	BLA	than	the	BLP	
(P <	0.001)	and	the	BLV	(P <	0.001;	BLP	vs	BLV,	P = 0.719). The 
interaction	 between	 group	 and	BLA	 region	was	 not	 significant	
(F4,48 =	0.77,	P =	0.552).
4  | DISCUSSION
The results of the present study indicate that treatment of adoles-
cent	 female	 rats	 with	 the	 GnRH	 antagonist,	 Antide,	 successfully	
suppressed	 the	 HPG	 axis	 and	 delayed	 pubertal	 development,	 as	
measured	by	reproductive	hormone	levels	and	the	timing	of	VO,	and	
Antide-treated	and	control	 females	exhibited	comparable	 levels	of	
social	behaviour	during	adolescence.	However,	contrary	to	our	pre-
dictions,	Antide-treated	females	did	not	differ	from	control	females	
in	 behavioural	 tests	 involving	 exploration	 of	 novel	 environments,	
novel	objects	or	novel	social	partners,	or	immobilisation	responses	
to	negative	acoustic	stimuli,	in	adulthood.	In	some	behavioural	tests,	
the	 expected	 sex	 differences	 in	 performance	 were	 observed;	 for	
F I G U R E  3  A,	Number	of	entries	onto	the	open	arms	(light	grey	
points) and closed arms (dark grey points) of the elevated-plus maze 
(EPM)	and	(B)	locomotion	in	the	open	field	(OF)	(total	number	of	
entries	into	sections),	by	control	males	(CM,	n	=	14),	Antide-treated	
females	(AF,	n	=	12	for	EPM,	n	= 13 for OF) and control females 
(CF,	n	= 14) (mean ±	SD).	*P <	0.05	(EPM	= repeated-measures 
ANOVA;	OF	=	one-way	ANOVA	with	Tukey’s	post-hoc	test)
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F I G U R E  4  A,	Locomotion	in	the	light-dark	box	(LDB)	(total	
number	of	entries	into	sections)	and	(B)	latency	to	enter	the	light	
section	of	the	LDB	(seconds),	by	control	males	(CM,	n	=	14),	
Antide-treated	females	(AF,	n	=	13)	and	control	females	(CF,	n	= 14) 
(mean ±	SD).	*P <	0.05	(one-way	ANOVA	with	Tukey’s	post-hoc	
test)
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example,	on	average,	control	males	exhibited	less	locomotion	in	the	
OF,	as	well	as	a	higher	preference	for	novel	objects	in	the	NOR	task,	
than	females,	with	Antide-treated	females	not	differing	from	control	
females	on	these	tasks.	In	addition,	no	group	differences	in	c-Fos	cell	
counts were found in nuclei of the medial and basolateral amygdala. 
Overall,	 these	 data	 suggest	 that	 a	moderate	 delay	 in	 exposure	 to	
gonadal hormones during adolescence does not significantly impact 
upon	anxiety-related	behavioural	and	brain	development	in	female	
rats,	which	contrasts	with	previous	studies	suggesting	that	adoles-
cent	exposure	to	testicular	hormones	has	subtle,	long-term	effects	
on behaviour in male rodents.24-28
One	of	the	benefits	of	using	GnRH	antagonists,	rather	than	ova-
riectomies,	to	manipulate	gonadal	hormone	levels	is	that,	once	the	
antagonist	has	been	metabolised,	the	HPG	axis	 is	reactivated.	The	
dose	of	Antide	used	in	the	present	study	was	identical	to	the	dose	
used	in	a	previous	study	in	our	laboratory,61 and this previous study 
confirmed	that	administration	of	Antide	on	PND	28	resulted	in	a	sig-
nificant suppression of progesterone levels for at least 2 weeks.61 In 
the	present	study,	Antide	was	administered	on	PND	28	and	again	on	
PND	42,	and	the	hormone	analyses	of	blood	samples	taken	2	weeks	
later	(PND	55/56)	showed	that	LH	and	progesterone	levels	in	Antide-
treated females were significantly lower than those of control fe-
males,	 confirming	 effective	 gonadotrophin	 and	 gonadal	 hormone	
suppression.	 The	 second	blood	 sample,	which	was	 taken	4	weeks	
after	 the	 second	Antide	 injection	 (PND	69/70),	 revealed	 that	pro-
gesterone	and	LH	levels	did	not	differ	between	Antide-treated	and	
control	 females	at	 this	point,	 indicating	 that	 the	 reproductive	axis	
was	reactivated.	Collectively,	these	data	confirm	that	the	HPG	axis	
can be temporarily suppressed in female rats by treatment with the 
GnRH	antagonist,	Antide.
With	regard	to	pubertal	development,	Antide-treated	females	ex-
hibited a modest delay (around 2-3 days) in the timing of VO relative 
to control females. This finding is consistent with previous evidence 
indicating	that	suppression	of	the	HPG	axis	in	adolescent	female	rats	
moderately	delays	pubertal	development,78 whereas treatment with 
oestrogenic compounds can induce early puberty.79,80	A	compara-
ble delay in VO (2-3 days) has been found in previous studies that 
exposed	 female	 rats	 to	either	 alcohol	or	 stress	during	 the	adoles-
cent period.81,82	The	delay	 in	VO	in	Antide-treated	female	rats	did	
not	appear	to	result	from	a	more	general	developmental	delay,	given	
that average body weight did not differ between the two groups of 
females.	 If	 anything,	 Antide-treated	 females	 gained	 slightly	 more	
weight	than	control	females,	which	is	consistent	with	evidence	that	
pre-pubertal ovariectomy leads to weight gain in female rats.33,35 
Average	AGD	did	not	differ	between	the	two	female	groups	and	thus	
AGD	does	not	appear	to	be	influenced	by	ovarian	hormone	exposure	
during this stage of life. This finding contrasts with studies of male 
F I G U R E  5  Percentage	of	time	spent	in	the	section	of	the	arena	
with the novel object (light grey points) and social partner (dark 
grey	points)	in	the	social	novelty	(SN)	test,	by	control	males	(CM,	
n =	14),	Antide-treated	females	(AF,	n	= 13) and control females 
(CF,	n	= 14) (mean ±	SD).	*P <	0.05	(repeated-measures	ANOVA	
with Tukey’s post-hoc test)
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F I G U R E  6  A,	Number	of	times	that	subjects	were	immobile	
following	the	startle	noise	and	(B)	total	duration	of	time	spent	
immobile	following	startle	noises	by	control	males	(CM,	n	=	14),	
Antide-treated	females	(AF,	n	=	13)	and	control	females	(CF,	n	= 14) 
(mean ±	SD).	*P <	0.05	(one-way	ANOVA	with	Tukey’s	post-hoc	
test)
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rodents	where	AGD	can	 show	some	plasticity	during	adolescence	
and adulthood in response to circulating androgen levels.28,83,84
During	adolescence,	Antide-treated	and	control	females	exhib-
ited	similar	 levels	of	social	 interactions	with	novel	partners,	which	
suggests	that	suppressing	the	HPG	axis	did	not	have	immediate	ac-
tivational effects on social behaviour. This finding is consistent with 
a previous study showing that the total amount of adolescent so-
cial play was not influenced by pre-pubertal ovariectomy in female 
rats.33	By	contrast,	 a	 recent	 study	 reported	 increased	 frequencies	
of play with a familiar partner following pre-pubertal gonadectomy 
in	 female	 Siberian	 hamsters.85	 In	 addition,	 subtle	 aspects	 of	 pos-
ture during social interactions have been shown to be influenced 
by	early	gonadal	hormone	exposure	 in	 rats,31,33 and so we cannot 
exclude	the	possibility	that	Antide	treatment	might	have	had	more	
fine-grained effects on social behaviour that were not evident in the 
present	study.	In	adulthood,	Antide-treated	and	control	females	did	
not	differ	 in	 their	 response	to	novel	male	partners	 in	 the	SN	task,	
although more subtle effects might again have been revealed using 
other measures. One such measure of interest would be the fre-
quency	and	type	of	ultrasonic	vocalisations	(USVs),	given	that	female	
rats	are	known	to	exhibit	high	levels	of	USVs	in	the	presence	of	novel	
social partners.86
Several	of	the	behavioural	tasks	involved	placing	subjects	into	a	
novel environment and measuring total locomotion and time spent 
in	the	potentially	aversive	areas	of	the	apparatus	(ie,	open	arms	of	
the	EPM,	centre	of	the	OF	and	light	area	of	the	LDB).	In	all	of	these	
tasks,	although	control	males	exhibited	lower	average	levels	of	loco-
motion	than	either	of	the	female	groups,	the	two	groups	of	females	
did	not	differ,	which	suggest	that	suppression	of	the	HPG	axis	in	fe-
males	does	not	have	long-term	effects	on	exploratory	behaviour.	By	
contrast,	pre-pubertal	gonadectomy	has	been	reported	to	increase	
exploratory	 behaviour	 in	 novel	 environments	 when	 tested	 during	
adolescence (in male rats24	and	female	Siberian	hamsters34),	which	
leaves open the possibility that peri-pubertal gonadal hormones 
have	 short-term	 effects	 on	 locomotor	 exploration.	 In	 the	 present	
study,	control	male	and	control	female	subjects	did	not	differ	in	the	
amount	 of	 time	 spent	 in	 the	 exposed	 sections	 of	 each	 apparatus,	
which	could	potentially	be	explained	by	the	handling	that	subjects	
received	 during	 adolescent	 testing.	 Adolescent	 handling	 has	 been	
shown	 to	 reduce	 later	 anxiety-like	 behaviour,87 whereas adoles-
cent social interactions per se do not alter behavioural responses on 
these tasks.88	The	lack	of	sex	differences	in	control	subjects	leaves	
open	 the	 possibility	 that	 the	 effects	 of	 suppressing	 the	HPG	 axis	
might	only	be	revealed	following	specific	adolescent	experiences.
In	 the	NO	 task,	 control	males	 exhibited	 a	 higher	 preference	
than	control	females	for	the	novel	object,	which	is	consistent	with	
the	sex	difference	that	we	have	previously	reported	in	adolescent	
rats.17	In	this	task,	Antide-treated	females	had	an	average	prefer-
ence score that was intermediate between that of control males 
and	control	females.	Similarly,	in	the	ASR	task,	the	number	of	im-
mobilisations	shown	by	Antide-treated	females	was	intermediate	
between	 the	 scores	 for	 control	 males	 and	 control	 females.	 By	
contrast,	 the	 total	 time	 spent	 immobile	 did	 not	 follow	 the	 same	
pattern	 and	 instead	 the	 standard	 sex	 difference	was	 replicated,	
with males on average spending more time immobile than both 
groups of females.60	 Although	 these	 data	 suggest	 that	 Antide-
treated females might differ slightly from control females on some 
measures	of	responsiveness	to	novelty	and	fear-inducing	stimuli,	
this interpretation of the results was not supported by the under-
lying brain activity because no differences in c-Fos labelling were 
evident between groups in the basolateral or medial amygdaloid 
nuclei. This lack of between-group differences in c-Fos measures 
was	unexpected,	given	the	sensitivity	of	the	BLA	to	stressors,	in-
cluding aversive acoustic noises.89	A	potential	explanation	is	that	
measures	of	immobilisation	in	the	ASR	task	do	not	strongly	reflect	
aversive	 responses,	 and	 future	 studies	 could	 benefit	 from	 em-
ploying	startle	amplitude	measures	instead.	Overall,	we	conclude	
that	suppressing	the	HPG	axis	during	adolescence	did	not	result	in	
marked behavioural effects or differences in c-fos activity in the 
basolateral or medial amygdaloid nuclei.
In	summary,	although	previous	research	has	suggested	that	ado-
lescent	exposure	to	ovarian	hormones	has	long-term	effects	on	sub-
tle	aspects	of	social	behaviour,30-32 the results of the present study 
do	 not	 provide	 strong	 evidence	 for	 similar	 effects	 on	 anxiety-like	
Control males
Antide-treated 
females
Control 
females
Medial	amygdala
(per mm2)
MeAD 46.95	±	15.56 54.56	±	16.13 60.26	±	34.69
MeAV 48.40 ± 31.72 38.41 ± 47.73 80.80 ±	59.85
MePD 24.28 ± 11.71 69.59	± 12.43 65.82	± 41.23
MePV 49.76	±	22.46 89.28 ± 28.44 93.96	±	108.85
Basolateral	amygdala	
(per mm2)
BLA*,# 38.14 ± 22.81 38.30 ± 18.44 27.43 ±	15.97
BLP 15.24	± 11.37 11.74 ± 9.42 14.66	± 12.09
BLV 20.41 ±	16.36 17.79 ±	31.67 11.49 ± 11.11
Abbreviations:	MeAD,	anterodorsal	medial;	MeAV,	anteroventral	medial;	MePD,	posterodorsal	
medial;	MePV,	posteroventral	medial;	BLA,	Basolateral	anterior;	BLP,	Basolateral	posterior;	BLV,	
Basolateral	ventral.
*P <	0.001	vs	BLP,	
#P <	0.001	vs	BLV	(repeated-measures	ANOVA).	
TA B L E  2   c-Fos+ cell counts in the 
medial and basolateral amygdaloid nuclei 
in control males (n =	14),	Antide-treated	
females (n = 13) and control females 
(n = 14) (per mm2; data are presented as 
the mean ±	SD)
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behaviour.	One	of	the	 limitations	of	previous	experimental	studies	
that	have	used	ovariectomy	techniques	is	the	possibility	that	the	sur-
gical procedure itself acts as a stressor and thus introduces a poten-
tial confounding factor.90	The	use	of	injectable	GnRH	antagonists	to	
suppress	the	HPG	axis	provides	a	useful,	alternative	approach.	Given	
that a range of factors can influence circulating gonadal hormone 
levels,	 including	alcohol	and	stress	exposure,91,92 the long-term ef-
fects	of	manipulating	the	HPG	axis	during	adolescence	deserve	con-
tinued investigation.
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